The webinar will feature a presentation from Key Opinion Leaders (KOL’s) Jeffrey S. Weber MD, PhD (NYU-Grossman School of Medicine) and Patrick Ott, MD, PhD (Dana Farber Cancer Institute). Dr. Weber who will discuss the current treatment landscape and unmet medical needs in patients with metastatic melanoma. Dr. Ott will then discuss the role and potential of novel peptide-based neoantigen therapies in oncology.

Following the presentations of Dr. Weber and Dr.Ott, Evaxion’s management team will provide a company update.

A live Q and A session will follow.